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Conclusions. Recent antibiotic therapy is the major risk fac-Clinical course of peritonitis due to Pseudomonas species com-
tor for peritonitis due to the Pseudomonas species. Exit siteplicating peritoneal dialysis: A review of 104 cases.
infection and recent antibiotic therapy are associated with poorBackground. Peritonitis due to Pseudomonas species is a
therapeutic response to antibiotics. When the therapeutic re-serious complication in continuous ambulatory peritoneal dial-
sponse is suboptimal, early Tenckhoff catheter removal mayysis (CAPD) patients. The clinical course of peritonitis due to
help preserve the peritoneum for further peritoneal dialysis.Pseudomonas complicating CAPD remains unclear.
Elective Tenckhoff catheter exchange after clearing up theMethods. All of the Pseudomonas species episodes of perito-
peritoneal dialysis effluent may also reduce the likelihood ofnitis in our dialysis unit were studied from 1995 to 1999. During
relapse. It is desirable to use third-generation cephalosporinthis period, there were 859 episodes of peritonitis recorded,
in the initial antibiotic regimen for peritonitis treatment in113 of which were caused by the Pseudomonas species. Nine
episodes were excluded because they were mixed growth. The localities with a high incidence of peritonitis due to the Pseu-
remaining 104 episodes in 68 patients were reviewed. domonas species.
Results. The underlying renal diagnosis and prevalence of
comorbid conditions of the 68 patients were similar to those
found in our entire dialysis population. There was a history of
Peritonitis due to the Pseudomonas species is a seriousantibiotic therapy within 30 days of the onset of peritonitis due
complication in continuous ambulatory peritoneal dial-to the Pseudomonas species in 69 episodes (66.3%). In 47
episodes (45.2%) there was a concomitant exit site infection. ysis (CAPD) patients [1–3], and is one of the most impor-
The overall primary response rate was 60.6% and the complete tant causes of technique failure in CAPD [3, 4]. A guide-
cure rate was 22.1%. The presence of exit site infection was
line for the management of CAPD peritonitis by the Adassociated with a lower primary response rate (22 in 47 vs.
Hoc Advisory Committee on Peritonitis Management41 in 57 episodes, P , 0.01) and a lower complete cure rate
(5 in 47 vs. 18 in 57 episodes, P , 0.02). The episodes that [the International Society of Peritoneal Dialysis (ISPD)
had received recent antibiotic therapy had a significantly lower protocol] recommends double antibiotic therapy, which
complete cure rate than the de novo cases (8 in 69 vs. 15 in may include a third-generation cephalosporin, aminogly-
35 episodes, P , 0.001). Episodes receiving third-generation
coside, or quinolone drugs [4, 5]. However, this recom-cephalosporin as part of the initial antibiotic regimen had a
mendation was based on a series of small clinical studiessignificantly higher primary response rate than the ones that
initially received aminoglycoside (54 in 81 episodes vs. 8 in 22 [1, 2, 6–9]. The clinical course of this notorious complica-
episodes, P , 0.05), but their complete cure rates were similar. tion remains unclear.
Twenty-four cases failed to respond to antibiotics and the In our locality, CAPD is the first-line renal replace-
Tenckhoff catheter was removed. The chance of returning to
ment therapy for all end-stage renal disease patientsCAPD was higher when the Tenckhoff catheter was removed
[3, 10]. Patients are switched to long-term hemodialysison day 10 than on day 15 (9 in 14 cases vs. 5 in 10 cases), al-
though the result was not statistically significant. The Tenckhoff only when they have ultrafiltration failure or peritoneal
catheter was removed and replaced at another site simultane- sclerosis. This policy has provided an excellent opportu-
ously in another 14 cases after the effluent cleared up. None nity to examine the clinical outcome of peritonitis dueof these patients had a relapse of peritonitis within three months.
to Pseudomonas species with contemporary therapy in
a large unselected group of CAPD patients in a retro-
Key words: renal failure, CAPD, antibiotics, bacterial infection, Tenck- spective study.
hoff catheter, cephalosporin therapy, exit site infection.
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Table 1. Loading and maintenance doses of antibiotics terium, either the Tenckhoff catheter was removed im-
for peritonitis
mediately or the antibiotics were changed (the “salvage
Maintenance antibiotics” group), as judged clinically by the individual
Drug Loading IP dosea IP dosea nephrologist. The salvage antibiotic regimens were gen-
Vancomycin 1000 mgb erally two of the following: amikacin, ciprofloxacin, or
Netromycin 150 mg if body weight , 50 kg 15 mg
piperacillin.200 mg if body weight $ 50 kg
Cephalosporinc 1000 mg 250 mg Tenckhoff catheters were removed and patients were
put on temporary hemodialysis when peritonitis faileda Per 2-liter dialysate; antibiotics were given intravenously when the patient
was septic or required rapid cycle dialysis for other reasons to resolve with antibiotics. Tenckhoff catheter reinser-
b Loading dose was given every five days as a maintenance dose
tion was attempted in all cases. As described in ourc Cephalosporins included cefazolin, ceftazidime, cefepime, and cefaperazone
plus sulbactam; cefazolin was used for the coverage of gram-positive organisms previous study [10], in our locality patients were switched
[4]; the loading dose of cefepime was 2000 mg IP when the drug was used as a
to long-term hemodialysis only when attempts at Tenck-monotherapy (that is, without vancomycin) [12]
hoff catheter reinsertion failed because of peritoneal ad-
hesion, or when there was ultrafiltration failure caused
by peritoneal sclerosis. In selected cases as judged by
of peritonitis was based on at least two of the following the individual nephrologist, the Tenckhoff catheter was
[11]: (1) abdominal pain or cloudy peritoneal dialysis removed and a new catheter was reinserted simultane-
effluent (PDE); (2) leukocytosis in PDE [white blood ously at a different site after the antibiotic treatment
cells (WBC) . 100/mL]; and (3) positive Gram stain or for the peritonitis episode was completed (the “catheter
culture from PDE. Episodes with peritoneal eosinophilia exchange” group). Early relapse was defined as recur-
but negative bacterial culture were excluded. A bacterial rence of peritonitis by the same organism within 30 days
culture of PDE was performed using BacTAlertt bottles of completion of the antibiotic treatment [13]. Late re-
(Organon Teknika Corp., Durham, NC, USA). Isolation lapse was defined as recurrence of peritonitis by the same
and identification were performed by standard tech- organism within 120 days of completion of antibiotics.
nique. Antibiotic sensitivity was determined by the com- Complete cure was defined as complete resolution of
parative disc-diffusion method. peritonitis by antibiotics alone within 120 days without
Over the five-year study period, 859 episodes of perito- relapse, salvage antibiotics, or catheter exchange. All of
nitis were recorded. One hundred thirteen episodes the patients were monitored for at least three months
(13.2%) were caused by the Pseudomonas species and after their treatment was completed.
nine episodes were excluded from analysis because the Statistical analysis was performed using SYSTAT 7.0
PDE cultures showed mixed bacterial growth. The case for Windows (SPSS Inc., Chicago, IL, USA). All data
records of the remaining 104 episodes in 68 patients were were expressed in mean 6 SD unless otherwise specified.
reviewed. The demographic characteristics, underlying Data were compared by the chi-square test, Fisher exact
medical conditions, previous peritonitis episodes, recent test, and Student t-test as appropriate. A P value of less
antibiotic therapy, antibiotic regimen for the peritonitis than 0.05 was considered significant. All probabilities
episode, requirement of Tenckhoff catheter removal, and were two tailed.
clinical outcome were examined. “Recent antibiotics” were
defined as antibiotic therapy within 30 days of the onset
RESULTSof peritonitis from the Pseudomonas species. Episodes
without recent antibiotics were called “de novo” cases. From 1995 to 1999, 859 episodes of peritonitis were
recorded in our unit. The overall peritonitis rate wasPeritonitis episodes were treated with our center’s
standard antibiotic protocol, which was changed systemi- 18.2 patient months per episode. One hundred thirteen
episodes (13.2%) were caused by the Pseudomonas spe-cally over time. Initial antibiotics for peritonitis generally
consisted of intraperitoneal administration of a third- or cies. Nine of these episodes were excluded from analysis
because the PDE culture showed mixed bacterial growth.fourth-generation cephalosporin, plus or minus vanco-
mycin, or cefazolin plus netilmicin. Antibiotic regimens The remaining 104 episodes of peritonitis from Pseu-
domonas species were reviewed in 68 patients. Theirfor individual patients were modified when culture re-
sults became available. The antibiotic dosing regimens demographic and baseline clinical data are summarized
in Table 2.are summarized in Table 1. In general, patients received
two antibiotics to which the isolated bacterium was sensi- The species of Pseudomonas isolated from PDE are
summarized in Figure 1. Most of the episodes were causedtive in vitro for at least 21 days [4]. Primary response
was defined as resolution of abdominal pain, clearing of by Pseudomonas aeruginosa. The isolated bacteria were
resistant to netilmicin in seven cases (6.7%). In two ofdialysate, and PDE neutrophil count of less than 100 per
mL on day 10 with antibiotics alone. If the PDE did not them, the patient had received netilmicin within 30 days
of the onset of the peritonitis episode. The bacteria iso-clear up on day 10 despite in vitro sensitivity of the bac-
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Table 2. Demographic and baseline clinical data
N of patients (%)
Total 68
Sex male:female 35:33
Agea years 55.3611.9
Duration on dialysisa months 35.8626.9
Renal diagnosis
Glomerulonephritis 23 (33.8%)
Diabetic nephropathy 16 (23.5%)
Polycystic kidney 4 (5.9%)
Hypertensive nephrosclerosis 4 (5.9%)
Obstructive uropathy 2 (2.9%)
Others/unknown 19 (27.9%)
Disconnect systema 58 (55.8%)
a Data of all 104 episodes were included because some patients had more than
one episode of peritonitis due to Pseudomonas species
Fig. 1. Prevalence of the identified Pseudomonas species.
lated were resistant to ceftazidime in five cases (4.8%),
to piperacillin in five cases (4.8%), and to amikacin in
three cases (2.9%). None of the patients had received Twelve patients (11.5%) died within three months
the corresponding antibiotic recently. In 47 episodes after the onset of peritonitis caused by Pseudomonas spe-
(45.2%), there was a concomitant exit site infection. How- cies. The causes of death were peritonitis from Pseudo-
ever, the same Pseudomonas species was isolated in only monas species per se (4 cases), fungal peritonitis (1 case),
21 episodes (20.2%).
cardiovascular disease (4 cases), termination of dialysis
(because of severe coexisting medical illnesses; 2 cases),Clinical outcome
and unrelated malignancy (1 case).The clinical outcome is summarized in Figure 2. The
overall primary response rate was 60.6% and the com-
Recent antibiotic therapyplete cure rate was 22.1%. The initial antibiotic regimen,
primary response rate, and complete cure rate of the There was a history of antibiotic therapy within 30 days
individual regimens are summarized in Figure 3. Epi- of the onset of peritonitis due to Pseudomonas species
sodes that received third-generation cephalosporin as in 69 episodes (66.3%; the post-antibiotic cases). Among
part of the initial antibiotic regimen had significantly the 746 episodes of peritonitis not from the Pseudomonas
higher primary response rates than the episodes where species, 147 episodes (19.7%) had a history of antibiotic
aminoglycoside was the initial therapy (54 of 81 episodes therapy within 30 days of the onset of peritonitis (P ,
vs. 8 of 22 episodes, P , 0.05). However, there was no dif- 0.0001).
ference in their complete cure rates (19 of 81 episodes vs.
For the peritonitis episodes due to Pseudomonas spe-3 of 22 episodes, P 5 0.39). The primary response rate
cies, antibiotics had been given in 29 cases (27.9%) toand complete cure rate were not associated with age,
treat recent peritonitis by other organisms, in 28 casessex, duration of dialysis, underlying renal diagnosis, or
(26.9%) due to exit site infection, and in 11 cases (10.6%)diabetic status (details not shown).
for unrelated medical reasons. The antibiotics given toThirty-four cases showed no clearing of PDE on day
these patients are summarized in Figure 4. Thirty-two10. The Tenckhoff catheter was immediately removed
patients (30.8%) had received two or more antibioticsin 14 cases, and 9 of them (64.3%) could return to CAPD
after a period of temporary hemodialysis. In the 20 cases within 30 days of the onset of peritonitis due to Pseudo-
that received salvage antibiotic therapy, 10 cases responded monas species.
within another five days (Fig. 2). There was no clinical Episodes receiving recent antibiotic therapy had a sig-
response in the other 10 cases, and the Tenckhoff cathe- nificantly lower complete cure rate than the de novo cases
ter was removed. Only five cases (50%) could return to (8 of 69 vs. 15 of 35 episodes, P , 0.001). Their primary
CAPD afterward. The presence of exit site infection of response rate also tended to be lower (38 of 60 vs. 25 of
any origin was associated with a lower primary response
35 episodes, P 5 0.11), but the result was not statisticallyrate (22 in 47 vs. 41 in 57 episodes, P , 0.01) and lower
significant. Of the 20 cases that received salvage-antibi-complete cure rate (5 in 47 vs. 18 in 57 episodes, P ,
otic therapy (Fig. 2), 13 had received recent antibiotics.0.02). Exit site infection from Pseudomonas species was
Only 3 of the 13 cases that had received recent antibioticsalso associated with a lower primary response rate (9 in
responded to salvage antibiotics. On the other hand, all21 vs. 54 in 83 episodes, P 5 0.063) and a lower complete
seven de novo cases responded to salvage antibioticscure rate (2 in 21 vs. 21 in 83 episodes, P 5 0.15), but
the result was not statistically significant. (P , 0.005).
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Fig. 2. Summary of clinical outcome. *One patient died of myocardial infarct two months later. **One patient died of malignancy six weeks later.
Fig. 3. Initial antibiotic regimen for the peri-
tonitis episodes and their relationship to the
clinical response. Symbols are: ( ) complete
cure; ( ) clearing by day 10; (h) no primary
response.
Peritonitis rate over five years remained similar over five years, but the incidence of
cases that had received recent antibiotics rose progres-The overall peritonitis rate and percentage of peritoni-
sively from 1995 to 1999 (Fig. 6).tis episodes caused by Pseudomonas species in our unit
from 1995 to 1999 are summarized in Figure 5. During
this period, the peritonitis rate in our unit improved from
DISCUSSION14.2 to 21.8 patient-months per episode. However, there
In this case series, we examined 104 consecutive epi-was a parallel rise in the percentage of peritonitis caused
sodes of peritonitis due to Pseudomonas species in ourby Pseudomonas species, from 7.1% in 1995 to 16.7%
unit from 1995 to 1999. To the best of our knowledge,in 1999. Further examination showed that the incidence
of de novo peritonitis from the Pseudomonas species this is the largest study to date of CAPD peritonitis
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Fig. 5. Overall peritonitis rate (d) and percentage of peritonitis epi-
sodes caused by Pseudomonas species (s) during the five-year study
period.
Fig. 6. Incidence of de novo peritonitis from Pseudomonas species
( ) and of episodes in patients who had recent antibiotic therapy ( ).Fig. 4. Recent antibiotic therapy prior to the onset of peritonitis due
to the Pseudomonas species. (A) Incidence of individual antibiotic
treatment and (B) number of antibiotics prescribed.
infection due to Pseudomonas species in peritoneal dial-
ysis patients [18]. It is possible that some unique localcaused by this notorious organism. Although this is a
retrospective study, most of the cases were managed factors exist that could account for our high rate of infec-
tion by Pseudomonas species in this region. Althoughaccording to contemporary guidelines [4, 14]. The clinical
course of our cases is therefore representative of cases our cases were not confined to summer, we believe the
warm and humid climate of Hong Kong, which favorsthat have received modern, state-of-the-art treatment.
Peritonitis from the Pseudomonas species accounted the accumulation of sweat and dirt around catheter exit
sites and contributes to the growth and colonization offor 13.2% of all CAPD peritonitis in the present study.
This incidence was substantially higher than many re- bacteria such as Pseudomonas species, was probably an
important factor. In fact, almost half of our cases hadported series [1, 2, 6–9], which might be partly explained
by the low incidence of Gram-positive peritonitis after pre-existing exit site infections.
During the study period, we worked vigorously to trywidespread utilization of disconnect peritoneal dialysis
systems [15–17]. Pseudomonas species accounted for to reduce the incidence of peritonitis from Pseudomonas
species. Although infection by the Pseudomonas species2.9% of the positive blood cultures and 6.3% of the
positive urinary cultures in our hospital during the same can occur from contaminated water taps or bathing wa-
ter, we do not think that explains our high prevalenceperiod. We do not believe the high incidence of peritoni-
tis due to the Pseudomonas species in this study is the of peritonitis due to Pseudomonas species. Furthermore,
as outlined in our previous series of peritonitis due toresult of a high overall rate of Pseudomonas species
infection in our hospital. Xanthomonas, almost all of our patients lived in an urban
area and received the usual domestic water supply [19].It is interesting to note that another group from Hong
Kong has also reported a high incidence of exit site In 1997, we performed bacterial cultures of the antiseptic
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solution and other peritoneal dialysis utilities for seven higher primary response rate with cephalosporin is cer-
tainly a desirable effect because the peritoneum as dial-cases of peritonitis due to Pseudomonas species, and
none of the facilities proved to be contaminated (unpub- ysis membrane is expected to be better preserved [25, 26].
In localities with a high incidence of peritonitis due tolished data). Before 1998, povidone-iodine painting was
used for exit site care in all of the cases at our center, Pseudomonas, we suggest the use of third-generation
cephalosporin as one of the initial antibiotics for treat-which might have encouraged the growth of resistant
organisms. Nevertheless, the incidences of exit site infec- ment of CAPD peritonitis. Interestingly, the recent ISPD
recommendation of peritonitis treatment also favorstion and peritonitis due to Pseudomonas species did not
decrease despite the adoption of soap and water for exit third-generation cephalosporin, although for different
reasons [5].site cleansing in mid-1998 (Figs. 5 and 6). We typically
treated exit site infections with chlorhexidine or hydro- Because of practical difficulties, immediate Tenckhoff
catheter removal was not possible and salvage antibioticsgen peroxide dressing, together with oral cloxacillin or
cefuroxime. Ciprofloxacin was used in cases of exit site were used in 20 cases when PDE failed to clear up on
day 10. Although half the cases responded, most of theseinfection due to Pseudomonas species because of its high
efficiency [20]. (7 out of 10) were de novo cases. Furthermore, of the
patients whose Tenckhoff catheter removal was delayedIn this case series, recent antibiotic therapy was an
important risk factor for a poor response to treatment. (that is, because they failed to respond to salvage antibi-
otics), half could not return to CAPD, mostly becauseNo other risk factor for developing peritonitis from Pseu-
domonas species was identified; the patients in the pres- of failed Tenckhoff catheter reinsertion. On the other
hand, when catheters were removed on day 10, two thirdsent study had a similar prevalence of diabetes, cardiovas-
cular disease, and chronic hepatitis when compared with of the patients could return to CAPD after a period
of temporary hemodialysis. Our finding highlights thethe entire peritoneal dialysis population as reported in
our previous studies [3, 10, 21]. importance of early Tenckhoff catheter removal once
the response to antibiotics is suboptimal.There are two possible explanations for our observa-
tion. First, use of antibiotics alters body flora and pro- As recommended by several small-scale studies [27–29],
vokes the development of resistant bacterial strains we performed Tenckhoff catheter exchange after PDE
[22, 23]. Although in vitro resistance to antibiotics was cleared up if the patient had persistent exit site infection
not common in the bacterial strains isolated from our (not necessarily caused by the Pseudomonas species).
patients (in 93 cases the isolated bacteria were sensitive We found this approach to be highly effective, and none
to all the anti-Pseudomonal species antibiotics tested), of the 14 cases had a relapse of peritonitis after the
it was probably not the Pseudomonas species itself that catheter exchange. This observation suggests that relapse
was resistant, but rather that the use of antibiotics had peritonitis is mostly caused by the persistence of bacterial
removed the normal bacterial flora and perhaps given biofilm on the peritoneal catheter, which has been shown
the Pseudomonas species a relative survival advantage. by many other groups [30, 31].
Liberal prescription of antibiotics was common among In summary, peritonitis due to the Pseudomonas spe-
family physicians in Hong Kong [24]. cies is a notorious complication of peritoneal dialysis.
Second, recent antibiotic therapy was a surrogate Recent antibiotic therapy is the major risk factor. Exit
marker of recent peritonitis or exit site infection (in over site infection and recent antibiotic therapy are associated
80% of cases, antibiotics had recently been prescribed with poor therapeutic response to antibiotics. In locali-
for either of these indications), either of which could ties with a high incidence of peritonitis from Pseudomo-
explain the poor clinical response. Peritonitis can spe- nas species, it is desirable to include third-generation
cifically alter local peritoneal defenses, and a thickened cephalosporin in the initial antibiotic regimen for CAPD
peritoneum may be more vulnerable to further peritoni- peritonitis. When the therapeutic response is suboptimal,
tis episodes. In our series, exit site infection from Pseu- early Tenckhoff catheter removal may help preserve the
domonas species alone was only marginally correlated peritoneum for further peritoneal dialysis. Elective Tenck-
with clinical response. hoff catheter exchange after PDE has cleared may also
Most of the episodes in the present study were treated reduce subsequent relapse.
with netilmicin plus a third-generation cephalosporin.
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